Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration

Science Translational Medicine

Volumn 4, Issue 132, 2012, Pages

  Zeitouni, Suzanne ^a   Krause, Ulf ^a   Clough, Bret H ^a   Halderman, Hillary ^a   Falster, Alexander ^b   Blalock, Darryl T ^a   Chaput, Christopher D ^a   Sampson, H Wayne ^a   Gregory, Carl A ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b University of New Orleans   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; MOLECULAR SCAFFOLD; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; 2-CHLORO-5-NITROBENZANILIDE; ALKALINE PHOSPHATASE; ANILIDE; COLLAGEN;

ANIMAL EXPERIMENT; ARTICLE; BONE DEFECT; BONE MATRIX; BONE MATURATION; BONE REGENERATION; BONE REMODELING; CALVARIA; CELL REGENERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; SKULL; TIME; WOUND HEALING;

ALKALINE PHOSPHATASE; ANILIDES; ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; COLLAGEN; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; SKULL; TIME FACTORS; WOUND HEALING;

EID: 84860782092     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003396     Document Type: Article

References (55)

1. D. Marsh, Concepts of fracture union, delayed union, and nonunion. Clin. Orthop. Relat. Res. 355, S22-S30 (1998).
2. United States Bone and Joint Decade: The Burden of Musculoskeletal Diseases and Musculoskeletal Injuries (American Academy of Orthopedic Surgeons, Rosemont, IL, 2008).
3. D. J. Hak, M. McElvany, Removal of broken hardware. J. Am. Acad. Orthop. Surg. 16, 113-120 (2008).
4. J. C. Banwart, M. A. Asher, R. S. Hassanein, Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 20, 1055-1060 (1995).
5. S. T. Kao, D. D. Scott, A review of bone substitutes. Oral Maxillofac. Surg. Clin. North Am. 19, 513-521 (2007).
6. H. T. Aro, A. J. Aho, Clinical use of bone allografts. Ann. Med. 25, 403-412 (1993).
7. S. D. Boden, Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27, S26-S31 (2002).
8. A. V. Cuomo, M. Virk, F. Petrigliano, E. F. Morgan, J. R. Lieberman, Mesenchymal stem cell concentration and bone repair: Potential pitfalls from bench to bedside. J. Bone Joint Surg. Am. 91, 1073-1083 (2009).
9. A. R. Derubeis, R. Cancedda, Bone marrow stromal cells (BMSCs) in bone engineering: Limitations and recent advances. Ann. Biomed. Eng. 32, 160-165 (2004).
10. D. G. Phinney, Biochemical heterogeneity of mesenchymal stem cell populations: Clues to their therapeutic efficacy. Cell Cycle 6, 2884-2889 (2007).
11. U. Krause, S. Harris, A. Green, J. Ylostalo, S. Zeitouni, N. Lee, C. A. Gregory, Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc. Natl. Acad. Sci. U.S.A. 107, 4147-4152 (2010).
12. C. N. Bennett, S. E. Ross, K. A. Longo, L. Bajnok, N. Hemati, K. W. Johnson, S. D. Harrison, O. A. MacDougald, Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277, 30998-31004 (2002).
13. S. R. Farmer, Regulation of PPARγ activity during adipogenesis. Int. J. Obes. 29 (Suppl. 1), S13-S16 (2005).
14. U. Krause, C. A. Gregory, Potential of modulating Wnt signaling pathway toward the development of bone anabolic agent. Curr. Mol. Pharmacol. 10.2174/1874212217872894672 (2011).
15. M. Moldes, Y. Zuo, R. F. Morrison, D. Silva, B. H. Park, J. Liu, S. R. Farmer, Peroxisomeproliferator- activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis. Biochem. J. 376, 607-613 (2003).
16. M. Hadjiargyrou, F. Lombardo, S. Zhao, W. Ahrens, J. Joo, H. Ahn, M. Jurman, D. W. White, C. T. Rubin, Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J. Biol. Chem. 277, 30177-30182 (2002).
17. T. A. Einhorn, The cell and molecular biology of fracture healing. Clin. Orthop. Relat. Res. 355, S7-S21 (1998).
18. R. Marsell, T. A. Einhorn, The biology of fracture healing. Injury 42, 551-555 (2011).
19. A. Schindeler, M. M. McDonald, P. Bokko, D. G. Little, Bone remodeling during fracture repair: The cellular picture. Semin. Cell Dev. Biol. 19, 459-466 (2008).
20. F. Shapiro, Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur. Cell. Mater. 15, 53-76 (2008).
21. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, E. Horwitz, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006).
22. R. Edgar, M. Domrachev, A. E. Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002).
23. GEO National Center for Biotechnology Information.
24. R. J. Midura, S. B. Midura, X. Su, J. P. Gorski, Separation of newly formed bone from older compact bone reveals clear compositional differences in bone matrix. Bone 49, 1365-1374 (2011).
25. A. I. Caplan, Why are MSCs therapeutic? New data: New insight. J. Pathol. 217, 318-324 (2009).
26. R. Tasso, M. Gaetani, E. Molino, A. Cattaneo, M. Monticone, A. Bachi, R. Cancedda, The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials 33, 2086-2096 (2012).
27. D. W. Huang, B. T. Sherman, R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
28. D. W. Huang, B. T. Sherman, R. A. Lempicki, Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
29. S. Gronthos, K. Stewart, S. E. Graves, S. Hay, P. J. Simmons, Integrin expression and function on human osteoblast-like cells. J. Bone Miner. Res. 12, 1189-1197 (1997).
30. B. Kehrel, A. Kronenberg, J. Rauterberg, D. Niesing-Bresch, U. Niehues, J. Kardoeus, B. Schwippert, D. Tschöpe, J. van de Loo, K. J. Clemetson, Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V. Blood 82, 3364-3370 (1993).
31. C. A. Gregory, D. J. Prockop, J. L. Spees, Non-hematopoietic bone marrow stem cells: Molecular control of expansion and differentiation. Exp. Cell Res. 306, 330-335 (2005).
32. M. Doi, A. Nagano, Y. Nakamura, Genome-wide screening by cDNA microarray of genes associated with matrix mineralization by human mesenchymal stem cells in vitro. Biochem. Biophys. Res. Commun. 290, 381-390 (2002).
33. M. I. Dishowitz, S. P. Terkhorn, S. A. Bostic, K. D. Hankenson, Notch signaling components are upregulated during both endochondral and intramembranous bone regeneration. J. Orthop. Res. 30, 296-303 (2012).
34. A. Iwaki, S. Jingushi, Y. Oda, T. Izumi, J. I. Shida, M. Tsuneyoshi, Y. Sugioka, Localization and quantification of proliferating cells during rat fracture repair: Detection of proliferating cell nuclear antigen by immunohistochemistry. J. Bone Miner. Res. 12, 96-102 (1997).
35. M. Yamazaki, R. J. Majeska, H. Yoshioka, H. Moriya, T. A. Einhorn, Spatial and temporal expression of fibril-forming minor collagen genes (types V and XI) during fracture healing. J. Orthop. Res. 15, 757-764 (1997).
36. D. Marvulli, D. Volpin, G. M. Bressan, Spatial and temporal changes of type VI collagen expression during mouse development. Dev. Dyn. 206, 447-454 (1996).
37. C. Wälchli, M. Koch, M. Chiquet, B. F. Odermatt, B. Trueb, Tissue-specific expression of the fibril-associated collagens XII and XIV. J. Cell Sci. 107 (Pt. 2), 669-681 (1994).
38. G. Lisignoli, K. Codeluppi, K. Todoerti, C. Manferdini, A. Piacentini, N. Zini, F. Grassi, L. Cattini, R. Piva, V. Rizzoli, A. Facchini, N. Giuliani, A. Neri, Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein. J. Cell. Physiol. 220, 401-409 (2009).
39. J. Fitzgerald, J. F. Bateman, A new FACIT of the collagen family: COL21A1. FEBS Lett. 505, 275-280 (2001).
40. Y. Sun, W. Li, Z. Lu, R. Chen, J. Ling, Q. Ran, R. L. Jilka, X. D. Chen, Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J. 25, 1474-1485 (2011).
41. K. U. Lewandrowski, C. Nanson, R. Calderon, Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: A report of five cases. Spine J. 7, 609-614 (2007).
42. B. Perri, M. Cooper, C. Lauryssen, N. Anand, Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: A case study. Spine J. 7, 235-239 (2007).
43. B. N. Robin, C. D. Chaput, S. Zeitouni, M. D. Rahm, V. A. Zerris, H. W. Sampson, Cytokine-mediated inflammatory reaction following posterior cervical decompression and fusion associated with recombinant human bone morphogenetic protein-2: A case study. Spine 35, E1350-E1354 (2010).
44. D. A. Wong, A. Kumar, S. Jatana, G. Ghiselli, K. Wong, Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J. 8, 1011-1018 (2008).
45. J. D. Smucker, J.M. Rhee, K. Singh, S. T. Yoon, J. G. Heller, Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31, 2813-2819 (2006).
46. H. H. de Boer, The history of bone grafts. Clin. Orthop. Relat. Res. 226, 292-298 (1988).
47. J. A. Rihn, K. Kirkpatrick, T. J. Albert, Graft options in posterolateral and posterior interbody lumbar fusion. Spine 35, 1629-1639 (2010).
48. A. Uccelli, L. Moretta, V. Pistoia, Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 36, 2566-2573 (2006).
49. C. A. Gregory, D. J. Prockop, in Culture of Human Stem Cells, R. I. Freshney, G. N. Stacey, J. M. Auerbach, Eds. (Wiley-Liss, Hoboken, NJ, 2007), p. 208.
50. C. A. Gregory, W. G. Gunn, A. Peister, D. J. Prockop, An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77-84 (2004).
51. U. Krause, A. Seckinger, C. A. Gregory, Assays of osteogenic differentiation by cultured human mesenchymal stem cells. Methods Mol. Biol. 698, 215-230 (2011).
52. G. Carraro, G. Albertin, M. Forneris, G. G. Nussdorfer, Similar sequence-free amplification of human glyceraldehyde-3-phosphate dehydrogenase for real time RT-PCR applications. Mol. Cell. Probes 19, 181-186 (2005).
53. T. Nemoto, H. Kajiya, T. Tsuzuki, Y. Takahashi, K. Okabe, Differential induction of collagens by mechanical stress in human periodontal ligament cells. Arch. Oral Biol. 55, 981-987 (2010).
54. F. Pattyn, F. Speleman, A. De Paepe, J. Vandesompele, RTPrimerDB: The real-time PCR primer and probe database. Nucleic Acids Res. 31, 122-123 (2003).
55. A. Schmidt, S. Lorkowski, D. Seidler, G. Breithardt, E. Buddecke, TGF-β1 generates a specific multicomponent extracellular matrix in human coronary SMC. Eur. J. Clin. Invest. 36, 473-482 (2006).